Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease

导出原文传递

翻译打印收藏纠错

作者： Stein, Ronen ^[1] ; Lee, Dale ^[2] ; Leonard, Mary B. ^[3] ; Thayu, Meena ^[4] ; Denson, Lee A. ^[5] ; Chuang, Emil ; Herskovitz, Rita ; Kerbowski, Theresa ; Baldassano, Robert N.

作者单位： Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 ^[1] Nestle Hlth Sci, Vevey, Switzerland ^[2] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA ^[3] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA ^[4] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Cincinnati, OH ^[5]

关键词 therapeutic drug monitoring loss-of-response biologic therapies

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交